According to the Zhitong Finance App, Jiuqiang Biotech (300406.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 394 million yuan, an increase of 5.49% over the previous year. Net profit attributable to shareholders of listed companies was 121 million yuan, an increase of 8.67% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 121 million yuan, an increase of 10.91% over the previous year.